CLPTM1L and neoplasm: High CLPTM1L expression was also associated with poor overall survival with a hazard ratio of 1.3 (p = 0.012) (Fig. 1g), particularly for those patients with a CA125 tumor marker level below the lowest quartile (HR = 2.14, p = 0.003) (Fig. 1h).